No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity - Watanabe, Shunji; Okamura, Yukishige; Yoshizumi, Hiroaki; Tahara, Toshiyuki; Imai, Masato; Kurata, Hidekazu; Numao, Norikatsu; Fukaya, Yukimura; Tano, Shigeo; Miura, Kouichi; Murayama, Kozue; Ozawa, Iwao; et al. (Internal Medicine, 2019)
Keywords: Antiviral agents; chronic hepatitis C infection; Chronic infection; Genotype & phenotype; genotype 2; Genotypes; Hepatitis C; Infections; Interferon; Internal medicine; Original; Patients; regional disparities; Ribavirin; sofosbuvir; sofosbuvir; ribavirin; genotype 2; regional disparities; chronic hepatitis C infection